The IPO Buzz: Required Reading
Two of this week’s nine IPOs have attracted some investors’ interest. One company is a spinoff providing a platform to streamline cloud software development and the other is developing next-generation cancer therapies to boost patients’ immune systems. All you need to know can be found in their prospectuses. For that matter, if you read the […]
April 15, 2018 Read More